<DOC>
<DOCNO>
EP-0007676
</DOCNO>
<TEXT>
<DATE>
19800206
</DATE>
<IPC-CLASSIFICATIONS>
C07F-9/00 C07F-9/02 <main>A61K-49/02</main> C07F-9/38 A61K-51/04 G01N-33/60 C07B-23/00 A61K-51/00 A61K-51/02 
</IPC-CLASSIFICATIONS>
<TITLE>
compositions for use as radiographic scanning agents.
</TITLE>
<APPLICANT>
procter & gambleus<sep>the procter & gamble company<sep>mallinckrodt, inc.(a missouri corporation)675 mcdonnell boulevard p.o. box 5840st. louis missouri 63134us<sep>the procter & gamble company<sep>
</APPLICANT>
<INVENTOR>
bevan john althorp<sep>bevan, john althorp<sep>bevan, john althorp975 avondale avenuecincinnati, 0h 45229us<sep>bevan, john althorp<sep>bevan, john althorp975 avondale avenuecincinnati, 0h 45229us<sep>
</INVENTOR>
<ABSTRACT>
a composition and method for the preparation of a  technetium-99m-based scanning agent are disclosed.  the  scanning agent is prepared from 99mtc, in a +3, +4 and/or  +5 oxidation state, and a methanehydroxydiphosphonate  bone-seeking agent which carries the radionuclide to bone  mineral.  the methanhydroxydiphosphonate agent provides  scan sharpness equivalent or superior to commercial scan­ ning agents, and is superior for detecting myocardial infarcts,  as compared with commercial scanning agents such as  ethane-1-hydroxy-1, 1-diphosphonate and methane­ diphosphonate.  
</ABSTRACT>
</TEXT>
</DOC>
